Financial Regulatory Pacira Completes Acquisition of MyoScience, Advancing Leadership in Non-opioid Pain Management with FDA-approved ioveraº System byJosh SandbergApril 9, 2019
Financial Top Stories Myoscience Announces Agreement to be Acquired by Pacira for up to $220 Million byJosh SandbergMarch 5, 2019
Recon OSN Interview with David Derminio – Executive Vice President Commercialization at Myoscience byJosh SandbergNovember 15, 2018
